Investing
Top Analyst Upgrades and Downgrades (APD, BERY, CL, CXS, DOW, FFIV, FMS, IMGN, LF, MCP, NS, OMC, PDLI, REGN, SGEN, WU, WY, XOMA)
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday.
Air Products & Chemicals Inc. (NYSE: APD) raised to Buy at Goldman Sachs.
Berry Plastics Group Inc. (NYSE: BERY) started as Buy at Goldman Sachs.
Colgate-Palmolive Co. (NYSE: CL) reiterated Buy and Focus List with $118 target at Argus.
Crexus Investment Corp. (NYSE: CXS) cut to Neutral at JPMorgan and cut to Hold at Deutsche Bank..
Dow Chemical Co. (NYSE: DOW) raised to Buy at Goldman Sachs.
F5 Networks Inc. (NASDAQ: FFIV) raised to Buy at Goldman Sachs.
Fresenius Medical Care A.G. (NYSE: FMS) raised to Conviction Buy List at Goldman Sachs.
ImmunoGen Inc. (NASDAQ: IMGN) started as Equal Weight at Morgan Stanley.
LeapFrog Enterprises Inc. (NYSE: LF) named as Value stock of the day at Zacks.
Molycorp Inc. (NYSE: MCP) cut to Equal Weight at Morgan Stanley.
NuStar Energy L.P. (NYSE: NS) raised to Neutral at Credit Suisse.
Omnicom Group Inc. (NYSE: OMC) reiterated Buy with $56 target at Argus.
PDL BioPharma (NASDAQ: PDLI) started as Neutral at Credit Suisse.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) started as Outperform at Credit Suisse.
Seattle Genetics Inc. (NASDAQ: SGEN) Started as Outperform at Credit Suisse.
Western Union Co. (NYSE: WU) cut to Underperform as Bear of the Day at Zacks.
Weyerhaeuser Co. (NYSE: WY) raised to Outperform as Bull of the Day at Zacks.
XOMA Corp. (NASDAQ: XOMA) started as Outperform at Credit Suisse.
JON C. OGG
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.